Abstract
Abstract
Background
Due to the inconsistent results of anti-treponema pallidum (TP) specific antibodies by enzyme-linked immunosorbent assay (ELISA) and Treponema pallidum granule agglutination assay (TPPA) in clinical work, there will be a certain proportion of false-positives and false-negatives depending on TPPA as confirmation results. This study aimed to evaluate the necessity of Western blotting (WB) in samples with inconsistent results in detecting anti-TP antibodies by ELISA and TPPA.
Methods
Specific anti-TP test results in our clinical laboratory were retrospectively analyzed. The specimens with a positive or a negative result, but with colored ELISA plates, were retested by TPPA. WB was used to confirm the suspicious results between ELISA and TPPA. The Chi-square test was used to analyze whether the difference was statistically significant.
Results
A total of 106,757 anti-TP specimens were screened by ELISA from August 2018 to December 2019; 3972 were retested by TPPA, and 3809 were positive by TPPA. ELISA and TPPA showed different results in 163 specimens. Among them, 29 specimens were negative and 134 were positive by ELISA; 76 were negative, 23 were positive, and 64 were “reserve” by TPPA; 93 were negative, 31 were positive, and 39 were suspicious by the WB confirmation test. Compared with WB, the difference in the results of ELISA and TPPA was statistically significant.
Conclusions
TPPA is an effective retest method for anti-TP antibody detection. If the results of anti-TP antibodies by ELISA and TPPA are inconsistent, it is necessary to use WB for confirmation.
Trial registration This retrospective analysis is in accordance with the ethical guidelines of China and approved by the second hospital of Jiaxing (jxey-2018048).
Funder
jiaxing science and technology bureau
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. National Center for STD control Ccfdcap, Venereology group Csod, Subcommittee on venereology Cda. Guidelines for diagnosis and treatment of syphilis, gonorrhea and genital Chlamydia trachomatis infection. Chin J Dermatol. 2020;53(3):168–79.
2. Zhuang YH, Tian Y, Chen Y, Tang J, Wang JQ, Li P, et al. Evaluation of the Determine Syphilis TP assay for the detection of antibodies against Treponema pallidum for the serodiagnosis of syphilis. Eur J Clin Microbiol Infect Dis. 2012;31(6):929–35.
3. Wang TT, Li Q, Yu JF, Xiao CY, Zhang LP. Application of TRUST, TP-ELISA and TPPA in the serologic diagnosis of syphilis. Natl J Androl. 2012;18(11):1020.
4. Mo X, Jin Y, Yang Y, Hu W. Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis. Eur J Med Res. 2010;15(2):66–9.
5. Li Z, Wang M, Ping L, Dong J, Yan Z, Feng Z. Consistency between treponema pallidum particle agglutination assay and architect chemiluminescent microparticle immunoassay and characterization of inconsistent samples. J Clin Lab Analy. 2015;29:4.